disclor f fnncl rlatn · 2020-06-15 · 1 disclor f fnncl rlatn in compliance with the standards...
TRANSCRIPT
1
DISCLOSURE OF FINANCIAL RELATIONSHIPS
In compliance with the standards set by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of the American Association for Cancer Research (AACR) that the information presented at CME activities will be unbiased and based on scientific evidence. To help participants make judgments about the presence of bias, the AACR has provided information that planning committee members, speakers, and abstract presenters have disclosed about financial relationships they have with commercial entities that produce or market products or services related to the content of this CME activity.
Relationships are abbreviated as follows: E, Employee of listed company, G, Grant/research support recipient, A, Advisor or review panel member, C, Consultant, S, Stock Shareholder, SB, Speakers’ Bureau, H, Honoraria, O, Other.
Last Name First Name Company Relationships Type Role
Abernethy Amy U.S. Food and Drug Administration No Relationships Speaker
Achilefu Samuel Washington University School of Medicine, McDonnell Genome Institute
Kingdom Capital Inc. C,O Program Committee
Adamson Peter Children’s Hospital of Philadelphia No Relationships Program Committee
Aguirre-Ghiso Julio Icahn School of Medecine at Mount Sinai HiberCell, LLC A,C,G, H,S,O
Program Committee
Ahdesmäki Miika AstraZeneca AstraZeneca E Speaker
Ainscow Edward Carrick Therapeutics Carrick Therapeutics E Speaker
Albini Adriana Fondazione MultiMedica Onlus, ITALY No Relationships Program Committee
Alimonti Andrea Institute of Oncology Research IOR Oncosence; AstraZeneca; Astellas Pharma Inc A,G,S Speaker
Alizadeh Ash Stanford University Roche, Genentech, Jannssen, Pharmacyclics, Gilead, Celgene, Chugai, Pfizer
C Speaker
Al-Lazikani Bissan Institute of Cancer Research Astex Pharmaceutical, GSK, Astellas Pharma, Definines AG
A,C,H,O Speaker
Alter Orly University of Utah Huntsman Cancer Institute Eigengene, Inc. O Speaker
Altorki Nasser Weill Cornell Medical College View point; TMRW; AstraZeneca; Angiocrine Bioscience
G,S Speaker
Amit Ido Weizmann Institute of Science No Relationships Program Committee
Amos Christopher Baylor College of Medicine No Relationships Speaker
Anafi Ron University of Pennsylvania No Relationships Speaker
Anderl Jan Merck KGaA Merck; EMD Serono E,O Speaker
Anderson Kenneth Dana-Farber Cancer Institute Sanofi-Aventis; Precision Biosciences; Millennium-Takeda; Janssen; Gilead; Celgene; Bristol-Myers Squibb
C Speaker
Last Name First Name Company Relationships Type Role
2
DISCLOSURE OF FINANCIAL RELATIONSHIPS
Angelo R. Michael Stanford University Ionpath A,C Program Committee, Speaker
Anurag Meenakshi Baylor College of Medicine No Relationships Speaker
Araojo RADM Richardae
U.S. Food and Drug Administration No Relationships Speaker
Arpaia Nicholas Columbia University Irving Medical Center Merck & Co., Inc.; GenCirq, Inc. C,S Speaker
Arruabarrena-Aristorena
Amaia Memorial Sloan Kettering Cancer Center No Relationships Speaker
Arthur Ronald American Association for Cancer Research No Relationships Program Committee
Azad Nilofer Johns Hopkins Sidney Kimmel Comp. Cancer Center No Relationships Program Committee
Bailey Howard University of Wisconsin Carbone Comp. Cancer Center
Forte; Capio BioSciences, Inc A Speaker
Baran Amy American Association for Cancer Research No Relationships Program Committee
Bargonetti Jill City University of New York at Hunter College and the Graduate Center
No Relationships Speaker
Barksdale Elizabeth American Association for Cancer Research No Relationships Program Committee
Barnholtz-Sloan Jill Case Western Reserve University School of Med. No Relationships Speaker
Barrette Anne Marie Icahn School of Medicine at Mount Sinai No Relationships Speaker
Bassik Michael Stanford University Medical Center Boehringer Ingleheim G Speaker
Baylin Stephen Johns Hopkins University School of Medicine MDxHealth, Mirati Therapeutics, Aminex Therapeutics
C,O Program Committee, Speaker
Bedard Philippe Princess Margaret Cancer Centre BMS, Genentech, Pfizer, Jazz Pharmaceuticals, Seattle, Genetics, Roche/Genentech, Merck, BMS, Sanofi, AstraZeneca, Lilly, Novartis, Zymeworks
G Program Committee
Bedrosian Isabelle UT MD Anderson Cancer Center No Relationships Speaker
Ben-David Uri Tel Aviv University No Relationships Speaker
Bendell Johanna Sarah Cannon Research Institute No Relationships Speaker
Berger Shelly University of Pennsylvania School of Medicine No Relationships Program Committee
Bergers Gabriele VIB-KU Leuven Center for Cancer Biology Oncurious O Speaker
Last Name First Name Company Relationships Type Role
3
DISCLOSURE OF FINANCIAL RELATIONSHIPS
Bernards René Netherlands Cancer Institute Oncosence S Speaker
Bertolini Giulia Fondazione IRCCS Istituto Nazionale Tumori No Relationships Speaker
Berx Geert Ghent University/VIB No Relationships Speaker
Bhardwaj Nina Mt. Sinai Medical Center Neon Therapeutics; Tempest Therapeutics; Checkpoint Sciences; Curevac; PICI; Novacure; Celldex; Genentech; Oncovir; Avidea; Primevax; Novartis; Array BioPharma; Roche; Rome, BI; Roswell Park; Janssen; Regeneron
A,G Program Committee
Bhatt Vrushank Rutgers Cancer Institute of New Jersey No Relationships Speaker
Biegel Jaclyn Children’s Hospital Los Angeles No Relationships Speaker
Bigot Ludovic Institut Gustave Roussy No Relationships Speaker
Biru Yelak International Myeloma Foundation No Relationships Speaker
Bivona Trever UCSF Revolution Medicines, Novartis, AstraZeneca, Array Biopharma, Jazz
A,C,G Speaker
Black Morgan London Health Sciences Center No Relationships Speaker
Blank Christian Netherlands Cancer Institute BMS, AZ, Pfizer, Lilly, GenMab, Pierre Fabre, Nanostring, Uniti Cars, MSD, Roche, Novartis, GSK
A,G,S Program Committee
Blank Christian Netherlands Cancer Institute/Antoni van Leeuwenhoek (NKI-AvL)
NanoString; BMS; BMS, MSD, Roche, Novartis, GSK, AZ, Pfizer, Lilly, GenMab, Pierre Fabre; BMS, Novartis, NanoString; Forty Seven; GenMab; GSK; AZ; MSD; Uniti Cars; Neon Therapeutics; Neon Therapeutics, Forty Seven, Unity Cars; Novartis; Pfizer; Pierre-Fab
A,G,S Speaker
Borghaei Hossein Fox Chase Cancer Center Takeda; Incyte; BMS; Lilly; Genentech; Celgene; Merck; EMD Serono; BI; AZ; Novartis; Genmab; Regeneron; BioNTech; Cantargia AB; Amgen; AbbVie; Axiom; PharmaMar; Huya Bio, GLG; Millennium; Pfizer; Sonnetbio; Rgenix; Daiichi Sankyo
A,C,G, H,O
Speaker
Boshoff Chris Pfizer, Inc. Medical Oncology Pfizer E Speaker
Bossard Carine Samumed, LLC Samumed, LLC E Speaker
Bozhanova Galabina The Institute of Cancer Research No Relationships Speaker
Last Name First Name Company Relationships Type Role
4
DISCLOSURE OF FINANCIAL RELATIONSHIPS
Brands Michael Bayer AG Bayer E Speaker
Breunig Joshua Cedars-Sinai Medical Center No Relationships Speaker
Brody Joshua Icahn School of Medicine at Mount Sinai Seattle Genetics; Merck; Kite; Genentech; Celldex; Celgene; BMS; Acerta
G Speaker
Brody Julia Silent Spring Institute No Relationships Speaker
Brummond Kay University of Pittsburgh No Relationships Speaker
Buhrlage Sara Dana-Farber Cancer Institute No Relationships Speaker
Burgenske Danielle Mayo Clinic No Relationships Speaker
Burslem George Perelman School of Medicine, University of Pennsylvania
No Relationships Speaker
Burzyn Dalia Codiak BioSciences Codiak BioSciences E Speaker
Buschhaus Johanna University of Michigan No Relationships Speaker
Byun Jinyoung Baylor College of Medicine No Relationships Speaker
Calin George UT MD Anderson Cancer Center No Relationships Speaker
Calizo Lyngine American Association for Cancer Research No Relationships Program Committee
Campbell Kerry Fox Chase Cancer Center NantKwest; Janssen Pharma; Immune Oncology Biosciences
G,O Speaker
Campbell Nathaniel Weill Cornell/Rockefeller/Sloan-Kettering Tri-Institutional MD-PhD Program
No Relationships Speaker
Campisi Judith Buck Institute for Research on Aging Unity Biotechnology G,S Program Committee
Cao Yin Washington University No Relationships Speaker
Cardoso Fatima Champalimaud Cancer Center Amgen, Astellas/Medivation, AstraZeneca, Celgene, Daiichi-Sankyo, Eisai, GE Oncology, Genentech, GlaxoSmithKline (GSK), Macrogenics, Merck-Sharp, Merus BV, Mylan, Mundipharma, Novartis, Pfizer, Pierre-Fabre, Roche, Sanofi, Seattle Genetics, Samsung Bioepis, Teva, Prime Oncology, Teva, BI, BMS, Fresenius, Ipsen,Incyte, Nektar Therapeutics, Nerviano, Medigene, Pfizer, Sonus, Tesaro, Tigris, Wilez, Wyeth
C,G,H Program Committee
Last Name First Name Company Relationships Type Role
5
DISCLOSURE OF FINANCIAL RELATIONSHIPS
Carr Steven Broad Inst. of MIT and Harvard No Relationships Speaker
Carroll Martin Univ. of Pennsylvania Janssen Pharmaceuticals; Incyte Pharmaceuticals
C,G Speaker
Chae Young Northwestern University Immuneoncia; AstraZeneca; Biodesix; Boehringher Ingelheim; Bristol-Myers Squibb; Counsyl; Foundation Medicine; Abbvie; Guardant Health; Tempus; Lexent Bio; Lilly Oncology; Merck; Neogenomics; Novartis; Roche/Genentech; Takeda; Freenome Honoraria/Advisory
G,A,SB Speaker
Chakraborty Abhishek The Cleveland Clinic Lerner Research Institute No Relationships Speaker
Chander Ashok Combinatorial Strategies, LLC and Cellanyx Combinatorial Strategies, LLC; Cellanyx E Speaker
Chang Howard Stanford University Spring Discovery; Boundless Bio; Arsenal Biosciences; Accent Therapeutics; 10x Genomics
A,C,S Speaker
Chen Alice National Cancer Inst. No Relationships Speaker
Chen Mei-Kuang University of Texas MD Anderson Cancer Center No Relationships Speaker
Chen Qing The Wistar Institute No Relationships Speaker
Chheda Milan Washington University UpToDate; NeoimmuneTech G,O Speaker
Chinegwudoh Francis Barts and the London NHS Trust No Relationships Speaker
Chowdhury Sreyan Columbia University GenCirq, Inc C Speaker
Christensen Brock Dartmouth Geisel School of Medicine No Relationships Speaker
Christofk Heather UCLA David Geffen School of Medicine Agios Pharamaceuticals, Pelage Pharmaceuticals
A,S Program Committee
Cocco Emiliano Memorial Sloan Kettering Cancer Center No Relationships Speaker
Coghill Anna H. Lee Moffitt Cancer Center and Research Institute No Relationships Speaker
Colditz Graham Washington University School of Medicine GRAIL, Inc. A Speaker
Contessa Joseph Yale University Springbank Pharma G Program Committee
Last Name First Name Company Relationships Type Role
6
DISCLOSURE OF FINANCIAL RELATIONSHIPS
Corcoran Ryan Massachusetts General Hospital Amgen, Array Biopharma, Astex Pharmaceuticals, Avidity Biosciences, BMS, Chugai, Fog Pharma, Fount Therapeutics, Genentech, LOXO, Merrimack, N-of-one, Novartis, Revolution Medicine, Roche, Roivant, Shionogi, Shire, Spectrum Pharmaceuticals, Symphogen, Taiho, Warp Drive Bio, Avidity Biosciences, Fount Therapeutics, nRichDx, Asana, AZ, Sanofi, C4, Elicio
A,C,G,S, SB,O
Program Committee, Speaker
Corey Eva University of Washington Janssen; Kronos Bio; Bayer Pharmaceuticals; Gilead; Sanofi
G Speaker
Coussens Lisa OHSU Knight Cancer Institute Zymeworks, Inc.; Verseau Therapeutics, Inc.; Syndax Pharmaceuticals, Inc.; Pharmacyclics, Inc.; Innate Pharma; CytomX Therapeutics, Inc.; Cell Signaling Technologies; Carisma Therapeutics, Inc.
A,C,G Speaker
Cravatt Benjamin The Scripps Research Institute Vividion Therapeutics; Pfizer; Eisai; Boundless Bio
A Speaker
Crawford Howard University of Michigan No Relationships Speaker
Crosby David Cancer Research UK No Relationships Program Committee, Speaker
Croucher Peter Garvan Institute of Medical Research Amgen G,SB Speaker
Cruz-Correa Marcia University of Puerto Rico Comp. Cancer Center BeiGene A Program Committee, Speaker
Cugnetti Ana Paula BioAtla BioAtla E Speaker
Cukierman Edna Fox Chase Cancer Center Trammel G Program Committee, Speaker
Curtis Christina Stanford University No Relationships Program Committee
Dang Chi Van The Wistar Institute Rafael, Dracen, Polaris A,H Program Committee
Daver Naval UT MD Anderson Cancer Center Pfizer; Novartis; Immunogen; Genentech; Forty Seven; Daiichi-Sankyo; BMS; Astellas; Agios; AbbVie
A,G,H Speaker
Davis Melissa Weill Cornell Medical College No Relationships Program Committee
Last Name First Name Company Relationships Type Role
7
DISCLOSURE OF FINANCIAL RELATIONSHIPS
Davis-Marcisak Emily Johns Hopkins School of Medicine No Relationships Speaker
Dawson Mark Peter MacCallum Cancer Center Storm Therapeutics; GlaxoSmithKline; CTX CRC; Cambridge Epigenetix
A,G,H Speaker
De Bono Johann Royal Marsden NHS Foundation Trust Astra Zeneca, Astellas Pharma, Bayer, Boehringer Ingelheim, Celgene; Genentech/Roche, Daiichi Sankyo, CellCentric, Genmab, GSK, Janssen Oncology, Merck Serono, Merck Sharp & Dohme; Menarini Silicon Biosystems; Orion Pharma GmbH; Pfizer, Qiagen, Sanofi Aventis, Sierra Oncology, Taiho; Eisai, BioXCel Therapeutics, Pfizer
A,G Program Committee
De Carvalho Daniel Princess Margaret Cancer Centre Pfizer; Nektar therapeutics G Speaker
De Marzo Angelo Johns Hopkins University School of Medicine Myriad Genetics; Janssen R&D; Cepheid Inc C,G Speaker
De Velasco Marco Kindai University Faculty of Medicine AstraZeneca G Speaker
de Vries E. G. Elisabeth University Medical Center Groningen, The Netherlands NSABP, Sanofi, Daiichi Sankyo, Amgen, Genentech, Roche, AZ, Synthon, Nordic Nanovector, G1 Therapeutics, Bayer, Chugai Pharma, CytomX Therapeutics, Radius Health
A,C,G Program Committee
Debnath Jayanta UCSF Vescor Therapeutics, LLC A Speaker
DeGregori James University of Denver No Relationships Speaker
Dehghannasiri Roozbeh Stanford University No Relationships Speaker
Delgoffe Greg University of Pittsburgh Western Oncolytics; TTMS, Inc.; TCR2 Therapeutics; Pieris Pharmaceuticals; Pfizer; Bluebird Bio
A,C,G,S Speaker
Della Peruta Marco Autolus Therapeutics Autolus Therapeutics E Speaker
Demetri George Dana-Farber Cancer Institute No Relationships Speaker
Denardo David Washington Univ. School of Medicine No Relationships Program Committee, Speaker
DeNicola Gina H. Lee Moffitt Cancer Center & Research Institute No Relationships Speaker
Dhar Shilpa UT MD Anderson Cancer Center No Relationships Speaker
Diaz Luis Memorial Sloan Kettering Cancer Center Thrive Detect; Personal Genome Diagnostics; Neophore; Merck; 4 Paws
A,C,G,S Speaker
Last Name First Name Company Relationships Type Role
8
DISCLOSURE OF FINANCIAL RELATIONSHIPS
Diaz-Meco Maria Sanford Burnham Prebys Medical Discovery Institute No Relationships Speaker
Dick John University of Toronto Trillium Therapeutics Inc; Celgene A,G,S Speaker
Diehn Maximilian Stanford University School of Medicine Roche, AstraZeneca, BioNTech Varian, Sanofi, Genyzme, CiberMed
C,G,S Speaker
Ding Ke Jinan University No Relationships Speaker
Dipersio John Washington University School of Medicine WUGEN; Rivervest Venture Partners; NeoImmune Tech; Magenta Therapeutics; Karyopharm Therapeutics; Incyte; Cellworks Group, Inc.; Celgene; Arch Oncology; Amphivena Therapeutics
A,C,G, H,O
Speaker
Dive Caroline Cancer Research UK Manchester Institute Ad Hoc, AZ, Merck, Ilumina, Angle, Amgen, Menarini, Astex, Bioven, Carrick, Taiho, Clearbridge, GSK, Bayer, BI, Roche, BMS, Novartis, Celgene
C,G Program Committee
Dixon Jesse Salk Institute No Relationships Speaker
Domcheck Susan Abramson Cancer Center of University of Pennsylvania
AZ, Clovis, BMS H Program Committee
Downing James St. Jude Children’s Research Hospital No Relationships Speaker
Dragovich Peter Genentech, Inc. Genentech, Inc. E Speaker
Drebin Jeffrey Memorial Sloan Kettering Cancer Center American Regent Pharma , Ionis Pharma, Alnylam Pharma
E,S Program Committee
Drilon Alexander Memorial Sloan Kettering Cancer Center Ignyta/Genentech/Roche; Loxo/Bayer/Lilly; Takeda/Ariad/Millenium; TP Therapeutics; AstraZeneca; Pfizer; Blueprint Medicines; Helsinn; Beigene; BergenBio; Hengrui Therapeutics; Exelixis; Tyra Biosciences; Verastem; AbbVie; 14ner/Elevation Oncology; Remedica Ltd.; ArcherDX; Monopteros; GlaxoSmithKlein, Teva, Taiho, PharmaMar
O,H,G Speaker
Dudley Andrew University of Virginia No Relationships Speaker
Dvorak Harold Beth Israel Deaconess Medical Center Angiex S,O Speaker
Echeverria Gloria Baylor College of Medicine No Relationships Speaker
Edmondson Scott AstraZeneca AstraZeneca E,S Speaker
Last Name First Name Company Relationships Type Role
9
DISCLOSURE OF FINANCIAL RELATIONSHIPS
Egeblad Mikala Cold Spring Harbor Laboratory MPM Gilead; CytomX; Blackstone Life Sciences Fund; Agios Pharmaceutical
C,H,S,O Speaker
Eggermont Alexander Institute Gustave Roussy Biocad, Biovent, BMS, CatalYm, FRAME, GI Innolife, GSK, IO Biotech, ISA Pharmaceuticals, MSD, Merck, Novartis, Roche, Sanofi, Sellas, RiverDiagnostics, SkylineDx, Theranovir
A,H,S,SB Program Committee
Elemento Olivier Weill Cornell Medical College of Cornell Univ. Volastra Therapeutics; Owkin; One Three Biotech; Genetic Intelligence; Freenome; Eli Lily, Janssen, Sanofi; Acuamark
O Speaker
Engels Eric National Cancer Institute No Relationships Speaker
Engstrom Lars Mirati Therapeutics Mirati Therapeutics E Speaker
Erez Ayelet Weizmann Institute of Science No Relationships Speaker
Estey Elihu Fred Hutchinson Cancer Research No Relationships Speaker
Evrard Yvonne Leidos Biomedical Research, Inc. No Relationships Speaker
Fashoyin-Aje Lola U.S. Food and Drug Administration No Relationships Speaker
Fatema Kaniz Idaho State University No Relationships Speaker
Fawell Stephen AstraZeneca AstraZeneca E,S Speaker
Fearon Douglas Cold Spring Harbor Laboratory No Relationships Speaker
Fedewa Stacey American Cancer Society No Relationships Speaker
Fedorov Andriy Brigham and Women’s Hospital, Harvard Medical School
No Relationships Speaker
Ferrara Katherine Stanford University No Relationships Speaker
Fertig Elana Johns Hopkins Sidney Kimmel Comp. Cancer Center Champions Oncology C Speaker
Filbin Mariella Dana Farber Cancer Institute No Relationships Speaker
Fischbach Claudia Cornell University No Relationships Speaker
Fisher Stewart C4 Therapeutics C4 Therapeutics E Speaker
Last Name First Name Company Relationships Type Role
10
DISCLOSURE OF FINANCIAL RELATIONSHIPS
Flaherty Keith Massachusetts General Hospital Cancer Center Clovis Oncology, Strata Oncology, Vivid Biosciences, Checkmate Pharmaceuticals, X4 Pharmaceuticals, PIC Therapeutics, Sanofi, Amgen, Asana, Adaptimmune, Fount, Aeglea, Shattuck Labs, Tolero, Apricity, Oncoceutics, Fog Pharma, Neon, Tvardi, xCures, Monopteros, Vibliome, Novartis, Genentech, BMS, Merck, Takeda, Verastem, Boston Biomedical, Pierre Fabre, Debiopharm
A,C,S Program Committee
Flavahan William Massachusetts General Hospital Charles River Laboratories O Speaker
Fong Christopher Memorial Sloan Kettering Cancer Center No Relationships Speaker
Fong Lawrence UCSF Roche/Genentech; Merck; Janssen; Dendreon; BMS; Bavarian Nordic; AbbVie
G Speaker
Ford Heide University of Colorado Denver School of Medicine No Relationships Speaker
Formenti Silvia Weill Cornell Medical College BMS; Varian; Janssen; Regneron; Eisai; Merck ; Celldex; Elekta; AstraZeneca; ViewRay; GSK; Bayer
G,H Program Committee, Speaker
Foti Margaret American Association for Cancer Research No Relationships Program Committee
Fourie Zirkelbach Jeanne U.S. Food and Drug Administration No Relationships Speaker
Freed-Pastor William MIT Koch Institute for Integrated Cancer Res. No Relationships Speaker
Friedl Peter Radboud Univ. Nijmegen Medical Ctr. LaVision Biotech; Grintech; Altum G,O Speaker
Fukumura Dai MGH/Harvard Medical School Merck; Eisai H Speaker
Galanis Evanthia Mayo Clinic College of Medicine AstraZeneca; Tracon; Genentech; BMS; Karyopharm
G,O Speaker
Galbraith Susan AstraZeneca AstraZeneca Pharmaceuticals LP, Horizon Discovery
A,E,S Program Committee
Galloway Denise Fred Hutchinson Cancer Research Center Merck A,G Speaker
Gao Jennifer U.S. Food and Drug Administration Worldcare, Inc C Speaker
Gao Jianjiong Memorial Sloan Kettering Cancer Center No Relationships Speaker
Garnett Mathew Wellcome Trust Sanger Institute AstraZeneca, Sanofi G,H Speaker
Gauttier Vanessa OSE Immunotherapeutics OSE Immunotherapeutics E Speaker
Last Name First Name Company Relationships Type Role
11
DISCLOSURE OF FINANCIAL RELATIONSHIPS
Geisler Stefanie Washington University Saint Louis No Relationships Speaker
George Daniel Duke University Medical Center No Relationships Speaker
Getz Kayla University of Michigan No Relationships Speaker
Ghobrial Irene Dana-Farber Cancer Institute GSK; Genentech; Sanofi; Janssen; Takeda; Celgene; Karyopharm; AbbVie; GNS; Cellectar; Adaptive MedScape
C,H Program Committee, Speaker
Ghosh Soma U.S. Food and Drug Administration No Relationships Speaker
Giannakis Marios Dana-Farber Cancer Institute Merck; Bristol-Myers Squibb G Speaker
Gibbs Lee USC Keck School of Medicine No Relationships Speaker
Gibbs Summer Oregon Health & Science University Inherent Targeting, LLC A Speaker
Gieffers Christian Apogenix AG Apogenix AG E Speaker
Gilkes Daniele Johns Hopkins University School of Medicine No Relationships Speaker
Gill Saar Univ. of Pennsylvania School of Medicine Tmunity Therapeutics; Intellia; Carisma Therapeutics
A,G,S Speaker
Gillison Maura The University of Texas MD Anderson Cancer Center Merck, Roche, Roche, EMB Sereno, Bayer Health CarePharm, BMS, AstraZeneca,
C,G,H, SB,O
Program Committee
Gimple Ryan University of California, San Diego No Relationships Speaker
Giordano Jessica University of Torino No Relationships Speaker
Goecks Jeremy OHSU Knight Cancer Institute GalaxyWorks A Speaker
Goel Sanjay Montefiore Medical Center No Relationships Speaker
Goldmacher Gregory Merck Merck E Speaker
Goodell Margaret Baylor College of Medicine No Relationships Program Committee
Goodman Karyn Icahn School of Medicine at Mount Sinai RenovoRx A Speaker
Goodrich David Roswell Park Cancer Institute No Relationships Speaker
Gormley Nicole U.S. Food and Drug Administration No Relationships Speaker
Gou Xuxu Baylor College of Medicine No Relationships Speaker
Goverse Gera OcellO B.V. OcellO B.V. E Speaker
Govindan Ramaswamy Washington University School of Medicine GENEPLUS; Achilles C Speaker
Last Name First Name Company Relationships Type Role
12
DISCLOSURE OF FINANCIAL RELATIONSHIPS
Gozgit Joseph Ribon Therapeutics, Inc Ribon Therapeutics, Inc E Speaker
Gradl Stefan Bayer AG Bayer AG E Speaker
Grandori Carla SEngine Precision Medicine SEngine Precision Medicine E Speaker
Greenberg Philip Fred Hutchinson Cancer Research Center & University of Washington
Juno Therapeutics, Fix Bio, Elpiscience, Nextech, Celsius
A,C,G,S Program Committee
Griffith Obi Washington University School of Medicine No Relationships Program Committee, Speaker
Grivennikov Sergei Fox Chase Cancer Center No Relationships Speaker
Grupp Stephan Children’s Hospital of Philadelphia Novartis, Kite, Servier, Novartis, Roche, GSK, Cure Genetics, Humanigen, CBMG, Jazz, Adaptimmune, TCR2, Eureka, Cellectis, Juno, Vertex, Patent
A,C,G,O Program Committee
Guerriero Jennifer Dana-Farber Cancer Institute Verseau Therapeutics; GlaxoSmithKline; Eli LIlly; Codagenix; Array BioPharma
C,G Speaker
Guise Theresa Indiana University School of Medicine No Relationships Program Committee
Guyton Kathryn International Agency for Research on Cancer (IARC) No Relationships Speaker
Guzman Monica Weill Cornell Medical College TemedOn; SeqRX; Cellectis; Amgen; AI Therapeutics
A,G,H Speaker
Haber Michelle Children’s Cancer Institute Australia No Relationships Speaker
Habowski Amber University of California, Irvine No Relationships Speaker
Hahn William Dana-Farber Cancer Institute Tyra Biosciences; Tyra; Thermo Fisher; Solvasta Ventures; Solvasta; Paraxel; MPM; KSQ Therapeutics; iTeos; Frontier Medicines
C,S,O Speaker
Halabi Susan Duke University No Relationships Program Committee
Hambardzumyan Dolores Icahn School of Medicine at Mount Sinai Merck C Speaker
Hamel Lauren Karmanos Cancer Institute, Wayne State University No Relationships Speaker
Hampel Heather The Ohio State University Comprehensive Cancer Center
Promega; Invitae Genetics; Genome Medical; 23andMe
A,C,S Speaker
Hartmaier Ryan AstraZeneca AstraZeneca E Speaker
Last Name First Name Company Relationships Type Role
13
DISCLOSURE OF FINANCIAL RELATIONSHIPS
Harvey R. Donald Emory University School of Medicine AbbVie, Amgen, Arqule, AstraZeneca, Boston Biomedical, Calithera, Celgene, Corvus, Eli Lilly, Five Prime Therapeutics, Genmab, Halozyme, Ignyta, Incyte, Meryx, Nektar, Pfizer, Regeneron, Rgenix, Sanofi, Syndax, Takeda, Tesaro, Vertex, Xencor, Takeda, Bristol-Myers Squibb, GlaxoSmithKline
C,G Speaker
Haubein Lisa American Association for Cancer Research No Relationships Program Committee
Heath James Institute for Systems Biology PACT, Isoplexis, Indi Molecular, Sofie Biosciences, Merck
A,C,G Speaker
Heller Daniel Memorial Sloan Kettering Cancer Center Nirova Biosense, Inc.; LipidSense, Inc.; Goldilocks Therapeutics, Inc.; Concarlo Holdings, LLC
A,S Program Committee, Speaker
Hellmann Matthew Memorial Sloan Kettering Cancer Center Merck, Bristol-Myers Squibb, AstraZeneca, Genentech/Roche, Nektar, Syndax, Mirati, Shattuck Labs, Blueprint Medicines, Immunai, PGDx, Shattuck Labs, Immunai
C,G,H, S,O
Program Committee
Herbst Roy Yale University School of Medicine AbbVie, ARMO Biosciences, AZ, Biodesix, Bolt Biotherapeutics, BMS, Lilly, EMD Serono, Genentech/Roche, Genmab, Halozyme, Heat Biologics, IMAB Biopharma, Immunocore, Loxo, Merck, Midas Health Analytics, Mirati, Nektar, NextCure, Novartis, Pfizer, Sanofi, Seattle Genetics, Shire PLC, Spectrum Pharmaceuticals, Symphogen, Takeda, Tesaro, Tocagen, Neon Therapeutics, Infinity Pharmaceuticals, Junshi Pharmaceuticals
A,C,G Speaker
Herold Marco The Walter and Eliza Hall Institute of Medical Research No Relationships Speaker
Herranz Daniel Rutgers Cancer Institute of New Jersey Rutgers Cancer Institute of New Jersey; NIH/NCI; New Jersey Commission on Cancer Research; Gabrielle’s Angel Foundation for Cancer Research; American Cancer Society (ACS); Alex’s Lemonade Stand Foundation
E,G Speaker
Hershman Dawn Herbert Irving Comprehensive Cancer Center No Relationships Program Committee
Last Name First Name Company Relationships Type Role
14
DISCLOSURE OF FINANCIAL RELATIONSHIPS
Hidalgo Manuel Weill Cornell Medicine Celgene; Pfizer; Novartis; MSD; EMD; Ipsem; Shire; SOBI; Champions Oncology; Agenus; Erytech; Pharmacyte; Bioline; BioOncotech; Oncomatrix; VCN; Bayer; BMS; Nelum; Eng T Cells
A,C,SB,O Program Committee, Speaker
Hilsenbeck Susan Baylor College of Medicine, Dan L. Duncan Cancer Center
No Relationships Speaker
Hirsch Jonathan Syapse Syapse E Speaker
Hirz Taghreed MGH/Harvard Medical School No Relationships Speaker
Hoppin Polly University of Massachusetts, Lowell No Relationships Speaker
Hosseinchi Peyman University of Chicago No Relationships Speaker
Hsiao Jennifer Harvard/MGH No Relationships Speaker
Huarte Maite University of Navarra No Relationships Speaker
Huguet Nathalie Oregon Health & Science University (OSHU) No Relationships Speaker
Hyman David Memorial Sloan Kettering Cancer Center Chugai Pharma, CytomX, BI, AZ, Pfizer, Bayer, Genentech/Roche, Loxo, Puma, Fount,
A,C,G, S,O
Program Committee
Issaq Sameer National Cancer Institute No Relationships Speaker
Jabado Nada McGill University No Relationships Program Committee, Speaker
Jacks Tyler Koch Institute for Integrative Cancer Research at MIT Amgen. ; Thermo Fisher Scientific. ; Dragonfly Therapeutics. ; T2 Biosystems. ; Skyhawk Therapeautics. ; SQZ Biotech. ; Calico
A,E Speaker
James Ashley American Association for Cancer Research No Relationships Program Committee
Jeon Junhyeok Korea Advance Institute of Science and Technology (KAIST)
No Relationships Speaker
Jiang Changying The University of Texas MD Anderson Cancer Center No Relationships Speaker
Jiang Qingfei UCSD No Relationships Speaker
Jiang Wen UT Southwestern Medical Center Spot BioSystems G Speaker
Jin Chengcheng University of Pennsylvania No Relationships Speaker
Johnstone Ricky Peter MacCallum Cancer Center, Australia MecRx, Roche, BMS A,C,G,S Program Committee
Last Name First Name Company Relationships Type Role
15
DISCLOSURE OF FINANCIAL RELATIONSHIPS
Jones Lyn Dana-Farber Cancer Institute Deerfield O Speaker
Jones Phil Wellcome Sanger Institute No Relationships Speaker
Kagawa-Singer Marjorie University of California No Relationships Speaker
Kakimi Kazuhiro University of Tokyo Hospital TAKARA BIO Inc.; MSD; Medinet Ltd. G,O Speaker
Kamm Roger Massachusetts Institute of Technology Gore; Elstar; Biogen; Amgen; AIM Biotech A,G,S Speaker
Kandimalla Raju Baylor Scott & White Research Institute No Relationships Speaker
Kang Yibin Princeton University Firebrand Therapeutics, Kayothera, Amgen, Glycomimetics, Cytocares
A,G,H,S Program Committee
Karchin Rachel Johns Hopkins University No Relationships Speaker
Karin Michael UC San Diego Johnson & Johnson Innovation, JLABS, Merck & Co., Genentech
G Speaker
Karthaus Wouter MSKCC Prostate Cancer Foundation; Organoid technology Co-Inventor
G,O Speaker
Kashima Kenji Chugai Pharmaceutical Co., Ltd. Chugai Pharmaceutical Co., Ltd. E Speaker
Kassiotis George The Francis Crick Institute No Relationships Speaker
Kastan Michael Duke Cancer Center XRad Therapeutics S Program Committee
Kaufman Howard Immuneering Corporation Immuneering Corporation E Speaker
Kaur Harpreet Johns Hopkins University School of Medicine No Relationships Speaker
Kaur Judith Mayo Clinic Florida No Relationships Speaker
Keegan Patricia U.S. Food and Drug Administration No Relationships Speaker
Kemp Christopher Fred Hutchinson Cancer Research Center SEngine Precision Medicine A,S Speaker
Kerbel Robert Sunnybrook Research Institute OncoHost; Novelty Nobility, Inc.; NedBiosystems; CSTS Healthcare, Inc.
A,C Speaker
Khalil Ahmad Case Western Reserve Univ. School of Med. No Relationships Speaker
Khurana Ekta Weill Cornell Medical College No Relationships Speaker
Kleinstern Geffen Mayo Clinic No Relationships Speaker
Kluetz Paul Food and Drug Administration No Relationships Speaker
Knopp Michael Ohio State University No Relationships Program Committee
Last Name First Name Company Relationships Type Role
16
DISCLOSURE OF FINANCIAL RELATIONSHIPS
Kolonin Mikhail The University of Texas Health Science Center at Houston
No Relationships Speaker
Koltun Elena Revolution Medicines Revolution Medicines E Speaker
Korkola James Oregon Health & Science University Convergent Genomics O Speaker
Koyfman Shlomo The Cleveland Clinic Varian medical systems; Uptodate; Merck; BristolmyersSquib; Bristol Myers Squib
G,H,O Speaker
Kozlova Edgar Icahn School of Medicine No Relationships Speaker
Kreeger Pamela University of Wisconsin Novartis G Speaker
Kregel Steven University of Michigan No Relationships Speaker
Kulasinghe Arutha School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Queensland University of Technology
No Relationships Speaker
Kumar Dhiraj Johns Hopkins Medicine No Relationships Speaker
Kuo Calvin Stanford University Surrozen, Inc. A Speaker
Kurebayashi Yutaka National Cancer Institute, National Institutes of Health No Relationships Speaker
Lacey James City of Hope No Relationships Speaker
Lam Wai Ling Macrina
German Cancer Research Center No Relationships Speaker
Landgren Ola Memorial Sloan Kettering Cancer Center Takeda; Janssen; BMS/Celgene; Binding Site; Amgen; Adaptive Biotech
A,G,H,O Speaker
Langer Corey University of Pennsylvania Merck, AbbVie, Bristol Myers Squibb, Pfizer, Lilly, AstraZeneca, Novartis, Roche/Genentech, Bayer/Onyx, Abbott, Morphotek, Biodesix, Clarient, Caris Dx, Vertex, Synta, Celgene, Boehringer-Ingelheim, Hospira, Helsinn, Clovis, Ariad (Takeda), Takai; Regeneron, Gilead, OSI (Astellas), GSK, Nektar, Advantagene, Inovio, StemCentrx, Guardant Health, Amgen, Synta, Agennix, SWOG, Peregrine, Incyte, PIK; PER; NOCR; Imedex, CCO; RTP, MLG, TRM, Web-MD
A,G,O Program Committee
Lathan Christopher Dana-Farber Cancer Institute No Relationships Program Committee
Lathia Justin The Cleveland Clinic Lerner Research Inst. No Relationships Speaker
Last Name First Name Company Relationships Type Role
17
DISCLOSURE OF FINANCIAL RELATIONSHIPS
Le Xiuning Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center
EMD Serono; Eli Lilly; Boehringer Ingelheim; AstraZeneca
G,A,C Speaker
Leboeuf Nicole Brigham and Women’s Hospital Seattle Genetics; Cor2Ed; Bayer C,H Speaker
Lee Irene Dana-Farber Cancer Institute No Relationships Speaker
Lee J. Jack UT MD Anderson Cancer Center No Relationships Program Committee
Lemery Steven U.S. Food and Drug Administration No Relationships Speaker
Leonard M. Kathryn American Association for Cancer Research No Relationships Program Committee
Li Albert Stanford University School of Medicine No Relationships Speaker
Li Jun UT MD Anderson Cancer Center No Relationships Speaker
Li Pui Kai The Ohio State University, College of Pharmacy No Relationships Speaker
Li Sha Sanford Burnham Prebys Medical Discovery Institute No Relationships Speaker
Li Sheng The Jackson Laboratory No Relationships Speaker
Li Shijie “Chris” ChemoCentryx ChemoCentryx E Speaker
Liang Han UT MD Anderson Cancer Center Precision Scientific Ltd; Precision Scientific A,S Speaker
Ligorio Matteo University of Texas Southwestern Medical Center No Relationships Speaker
Lissanu Deribe Yonathan UT MD Anderson Cancer Center no company O Speaker
Liu Edison The Jackson Laboratory No Relationships Program Committee
Liu Jie Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine in St. Louis
No Relationships Speaker
Liu Ke U.S. Food and Drug Administration No Relationships Speaker
Liu Minmin Van Andel Research Institute No Relationships Speaker
Llor Xavier Yale University School of Medicine Exact Sciences A Speaker
Lopes Gilberto University of Miami No Relationships Speaker
Lopes-Ramos Camila Harvard T.H. Chan School of Public Health No Relationships Speaker
Lopez Juanita The Royal Marsden Hospital (Sutton, Surrey) Roche-Genentech. ; Basilea. ; Genmab G,A Speaker
Lu Sai San Moon Umeå University No Relationships Speaker
Last Name First Name Company Relationships Type Role
18
DISCLOSURE OF FINANCIAL RELATIONSHIPS
Luca Bogdan Stanford University No Relationships Speaker
Lund Amanda Oregon Health and Science University No Relationships Program Committee
Lynch Lydia Trinity College Dublin Novo Nordisk G Speaker
Lyssiotis Costas University of Michigan No Relationships Speaker
Mack Jennifer Dana-Farber Cancer Institute No Relationships Speaker
Maddocks Oliver University of Glasgow Faeth Therapeutics Inc. A,S Speaker
Madhavan Subha Georgetown University Medical Center No Relationships Program Committee
Malinou Justin University of Maryland Greenebaum Comprehensive Cancer Center
No Relationships Speaker
Malkin David The Hospital for Sick Children Bayer Canada C Speaker
Mallick Parag Stanford University No Relationships Speaker
Manguso Robert Massachusetts General Hospital/Broad Institute Calico Life Sciences LLC G Speaker
Mano Hiroyuki National Cancer Center Research Institute, Tokyo, Japan
No Relationships Program Committee
Manor Uri Salk Institute Cancer Ctr. No Relationships Speaker
Mansfield James Magnetic Insight Magnetic Insight, Andor Technology E Speaker
Marabelle Aurelien Institute Gustave Roussy No Relationships Speaker
MARCHETTI DARIO UNM Health Sciences Center No Relationships Speaker
Marcus Daniel Washington University School of Medicine Sora Imaging Solutions; Radiologics, Inc O Speaker
Mardis Elaine Nationwide Children’s Hospital Qiagen NV; Pact Pharma LLC; Moderna Inc.; Interpreta LLC
A,S Program Committee, Speaker
Marson Alexander UCSF Arsenal Biosciences O Speaker
Martin Sarah American Association for Cancer Research No Relationships Program Committee
Martinek Jan Jackson Laboratory No Relationships Speaker
Martinez Elena University of California, San Diego No Relationships Program Committee
Marx Matthew Mirati Therapeutics Reglagene; Mirati Therapeutics A,E,S Speaker
Matei Daniela Northwestern University - Chicago, IL Radius; Merck G,H Speaker
Matyskiela Mary Celgene Corporation Celgene Corp. E Speaker
Last Name First Name Company Relationships Type Role
19
DISCLOSURE OF FINANCIAL RELATIONSHIPS
Mazor Tali Dana-Farber Cancer Institute No Relationships Speaker
McAllister Florencia UT MD Anderson Cancer Center No Relationships Speaker
McHugh Colleen University of California, San Diego No Relationships Speaker
Mechta-Grigoriou Fatima Institut Curie Roche; Innate Pharma; BMS G,O Speaker
Melendez Brenda UT MD Anderson Cancer Center No Relationships Speaker
Melief Cornelis Leiden University Medical Center and ISA Pharmaceuticals
ISA Pharmaceuticals; Immatics A,E,S Speaker
Mellman Ira Genentech, Inc. Genentech E Program Committee
Merad Miriam Mount Sinai School of Medicine No Relationships Speaker
Mesa Ruben Mays Cancer Center at UT Health San Antonio Incyte; BMS; CTI; Novartis; AbbVie; Genentech; Sierra Oncology
G,H Speaker
Mesirov Jill UCSD No Relationships Program Committee, Speaker
Metcalfe Ciara Genentech, Inc. Genentech, Inc. E Speaker
Mischel Paul Ludwig Institute for Cancer Research Boundless Bio, Inc. S,O Speaker
Modlin Irvin Yale University School of Medicine Wren Laboratories C Speaker
Mole David University of Oxford No Relationships Speaker
Mooney David Harvard University No Relationships Speaker
Moore Malcolm Princess Margaret Hospital Gilead C Program Committee
Morgan Gareth NYU Langone Health Takeda; Sanofi; Roche; Karyopharm; GSK; Celgene
C,H Speaker
Morita Ken Dana-Farber Cancer Institute No Relationships Speaker
Mu Ping UT Southwestern Medical Center No Relationships Speaker
Mullooly Maeve Royal College of Surgeons in Ireland No Relationships Speaker
Nelson Shakira American Association for Cancer Research No Relationships Program Committee
Nephew Kenneth Indiana University School of Medicine Pfizer Pharmaceutical Company; Astex Pharmaceuticals Inc.
G Speaker
Newman Lisa Weill Cornell Medicine No Relationships Speaker
Nolan Garry Stanford University School of Medicine Ionpath; Akoya Biosciences A,S Speaker
Last Name First Name Company Relationships Type Role
20
DISCLOSURE OF FINANCIAL RELATIONSHIPS
Nooka Ajay Emory University Winship Cancer Institute Janssen Pharmaceuticals; Takeda; Karyopharm; Spectrum; Oncopeptides; GSK
H,A,O Speaker
Nwokeji Esmond McKesson Life Sciences McKesson Life Sciences E Speaker
Obeng Esther St. Jude Children’s Research Hospital No Relationships Speaker
Odunsi Kunle Roswell Park Cancer Institute No Relationships Program Committee
Ohashi Pamela Princess Margaret Cancer Centre No Relationships Program Committee
Oike Naoki University of Colorado Anschutz Medical Campus No Relationships Speaker
Olive Kenneth NY Presbyterian Hospital Herbert Irving Comp. Cancer Center
No Relationships Speaker
Oliver Trudy University of Utah Huntsman Cancer Institute No Relationships Speaker
Olopade Olufunmilayo University of Chicago Medical Center CancerIQ Inc, Tempus, Roche A,G Program Committee
Othus Megan Fred Hutchinson Cancer Research Center Merck; Glycomimetics; Daiichi Sankyo; Celgene C,O Speaker
Pacold Michael NYU Langone Medical Center Thermo Fisher Scientific; Raze Therapeutics C,O Speaker
Pagel Mark UT MD Anderson Cancer Center No Relationships Speaker
Palmer Adam University of North Carolina at Chapel Hill No Relationships Speaker
Pardee Timothy Wake Forest University Rafael Pharmaceuticals; Pharmacyclics; Amgen C,SB Speaker
Parikh Aparna Massachusetts General Hospital Tesaro; Puretech; Novartis; Natera; Guardant; Genentech; Foundation Medicine; Eli Lily; Eli Lilly; BMS; Array
A,C,O Speaker
Park Morag McGill University, Montréal, Canada No Relationships Program Committee
Parolia Abhijit University of Michigan No Relationships Speaker
Paulovich Amanda Fred Hutchinson Cancer Research Center Precision Assays, LLC O Speaker
Pearce Celeste Leigh University of Michigan School of Public Health No Relationships Speaker
Pe’er Dana Memorial Sloan Kettering Cancer Center No Relationships Speaker
Percac-Lima Sanja Massachusetts General Hospital Merck Foundation C,G,H Speaker
Perl Alexander University of Pennsylvania NewLink Genetics; Leukemia & Lymphoma Society; Forma Therapeutics; Daiichi Sankyo; Bayer; Astellas; Arog; Actinium Pharmaceuticals; Abbvie
C,G,H,O Speaker
Last Name First Name Company Relationships Type Role
21
DISCLOSURE OF FINANCIAL RELATIONSHIPS
Peters Solange Centre Hospitalier Universitaire Vaudois Debiopharm, Eli Lilly, Roche, Illumina, Janssen, MSD, Merck Serono; Daiichi Sankyo, Novartis, Pharma Mar, Pfizer, Regeneron, Seattle Genetiocs; Boehringer Ingelheim; BMS, Takeda, Vaccibody; Biovent; Biocartis; Bayer; Astra Zeneca; Amgen; Abbvie
A,H Speaker
Petersen Gloria Mayo Clinic No Relationships Program Committee
Peyton Shelly University of Massachusetts - Amherst No Relationships Speaker
Pfister Stefan Hopp Children’s Cancer Center Heidelberg (KiTZ) IMI-2 funding involving several EFPIA companies
G Speaker
Philippar Ulrike Janssen R&D Janssen R&D E Speaker
Phillips Andrew C4 Therapeutics C4 Therapeutics E Speaker
Piaggio Eliane INSERM U872 (Cordeliers Research Ctr.) Hifibio; Egle Therapeutics; Crown Bioscience C,S Speaker
Piantadosi Steven Brigham and Women’s Hospital No Relationships Program Committee
Pierga Jean-Yves Institute Curie Roche Genentech; Pfizer; Novartis; Daiichi Sankyo; Astra Zeneca
G,A,H Speaker
Pike Kurt AstraZeneca GlaxoSmithKline; AstraZeneca E,S Speaker
Plevritis Sylvia Stanford University No Relationships Speaker
Politi Katerina Yale Cancer Center Roche/Genentech; MSKCC/MolecularMD; AstraZeneca; Dynamo Therapeutics; Maverick Therapeutics
C,G,O Program Committee, Speaker
Pollak Michael McGill University and Segal Cancer Centre, Canada No Relationships Program Committee
Pouwels Jeroen University of Helsinki Galapagos; Biomedicum Genomics; Bayer; Astrazeneca
C,SB Speaker
Prabhu Varun Vijay Oncoceutics, Inc. Oncoceutics, Inc. E Speaker
Prasad Vinay University of California several universities, medical centers, nonprofit groups, and professional societies; Patreon; Medscape; Johns Hopkins University Press; Arnold Ventures
G,H,O Speaker
Pugh Trevor University of Toronto Merck, Chrysalis Biomedical C,H Program Committee
Puig-Saus Cristina David Geffen School of Medicine at UCLA ArsenalBio O Speaker
Last Name First Name Company Relationships Type Role
22
DISCLOSURE OF FINANCIAL RELATIONSHIPS
Pylayeva-Gupta Yuliya UNC Lineberger Comp. Cancer Center NCI; Department of Defense G Speaker
Quijano-Rubio Alfredo University of Washington Neoleukin Therapeutics S Speaker
Raben David University of Colorado Cancer Center and Genentech Genentech; EQRx E Speaker
Raca Gordana Children’s Hospital of Los Angeles No Relationships Program Committee, Speaker
Ramalingam Suresh Emory University Winship Cancer Institute Amgen, Abbvie, BMS, Genentech, Merck, AstraZeneca, Takeda, Tesaro, Advaxis
C,G Program Committee
Ramirez Amelie UT Health Science Center at San Antonio No Relationships Speaker
Rassool Feyruz University of Maryland School of Medicine No Relationships Speaker
Rathmell Jeffrey Vanderbilt Univ. Medical Ctr. Tempest; Sitryx; Pfizer; Merck; Kadmon; Incyte; Caribou Biosciences; Calithera
A,G,H,S Speaker
Rebbeck Timothy Harvard School of Public Health No Relationships Program Committee
Rebecca Vito Univ. of Pennsylvania No Relationships Speaker
Redman Mary Fred Hutchinson Cancer Research Ctr. No Relationships Speaker
Reis-Filho Jorge Mem. Sloan Kettering Cancer Ctr. Volition RX; Ventana Medical Systems; Roche Tissue Diagnostics; REPARE Therapeutics; Paige.AI; Novartis; InVicro; Goldman Sachs; Genentech
A,C Speaker
Ren Bing UCSD School of Medicine Decipher Biosciences; Aviva Systems Biology; Arima Genomics, Inc.
A,S Speaker
Rescigno Maria Humanitas University Postbiotica; MillBo; Kraft-Heinz; Intercept pharmaceuticals; Gelesis; Casillo group
A,G,S Speaker
Reticker-Flynn Nathan Stanford University No Relationships Speaker
Retzlaff Jon American Association for Cancer Research No Relationships Program Committee
Riaz Nadeem Memorial Sloan Kettering Cancer Center REPARE Therapuetics; Pfizer; BMS C,G Speaker
Ribas Antoni UCLA Medical Center Amgen, Chugai, Genentech, Merck, Novartis, Sanofi, Advaxis, Arcus, Highlight, Compugen, CytomX, Five Prime, RAPT, ImaginAb, Isoplexis, Kite-Gilead, Merus, Rgenix, Lutris, PACT Pharma, Tango Therapeutics
A,C,H, S,O
Program Committee, Speaker
Rigamonti Nicolo Molecular Partners AG Molecular Partners AG E Speaker
Last Name First Name Company Relationships Type Role
23
DISCLOSURE OF FINANCIAL RELATIONSHIPS
Rimm David Yale University School of Medicine Amgen; AZ; Biocept; BMS; Cell Signaling Technology; Cepheid; Daiichi Sankyo; GSK; Konica/Minolta; Merck; Nanostring; Ventana; Ultivue; Navigate BioPharma; NextCure; Lilly; Akoya/Perkin Elmer; PixelGear; Rarecyte
A,C,G, H,S,O
Program Committee, Speaker
Rivero-Hinojosa Samuel Children’s National Hospital No Relationships Speaker
Rodon Ahnert Jordi UT MD Anderson Cancer Center Spectrum Pharmaceuticals Inc; BioAtla; Pfizer; GenMab; Tocagen; CytomX Symphogen; Roche Pharmaceuticals; Pfizer; Orion Pharmaceuticals; IONCTURA SA; Kelun Pharmaceutical/Klus Pharma; Peptomyc; Ellipses Pharma; Eli Lilly, Bayer
A,G,O Speaker
Rosenberg Steven National Cancer Institute No Relationships Speaker
Rubin Joshua Washington University School of Medicine No Relationships Program Committee, Speaker
Rubinstein Wendy U.S. Food and Drug Administration AstraZeneca E Speaker
Rudolph Joachim Genentech, Inc. Genentech, Inc. E,S Speaker
Sadelain Michel Memorial Sloan Kettering Cancer Ctr. No Relationships Program Committee
Sahin Ugur BioNTech AG BioNTech AG E,O Speaker
Sahni Nidhi UT MD Anderson Cancer Center No Relationships Speaker
Sarkaria Jann Mayo Clinic College of Medicine Novartis. ; Basilea. ; Genentech. ; Sanofi. ; Beigene. ; Lilly. ; Glaxo-Smith-Kline. ; Peloton. ; Glionova. ; Bristol-Myers Squibb Pharmaceuticals. ; Cavion. ; Curtana. ; Forma. ; Abbvie. ; Actuate. ; Boehringer Ingelheim. ; Bayer. ; Celgene. ; Cible. ; Wayshine
G Speaker
Sasso Maria Stella University of Chicago No Relationships Speaker
Satchi-Fainaro Ronit Tel Aviv University Teva Pharmaceutical Industries Ltd.; Merck A,G Speaker
Satpathy Shankha Broad Institute of MIT and Harvard No Relationships Speaker
Sayem Mohammad Keio University No Relationships Speaker
Last Name First Name Company Relationships Type Role
24
DISCLOSURE OF FINANCIAL RELATIONSHIPS
Schalper Kurt Yale University Clinica Alemana Santiago; Celgene; Moderna Therapeutics; Shattuck Labs; Pierre-Fabre, AstraZeneca; Dyanamo Therapeutics; EMD Serono; Takeda; Torque Therapeutics; Agenus; Genoptix/Navigate (Novartis); Vasculox/Tioma; Tesaro; Onkaido Therapeutics; Takeda Pharmaceuticals; Surface Oncology; Pierre-Fabre Research Institute; Merck; Bristol-Myers Squibb; Eli Lilly; Fluidigm
C,G,SB Speaker
Schedin Pepper Oregon Health & Science University No Relationships Speaker
Scheet Paul UT MD Anderson Cancer Center No Relationships Speaker
Schilder Russell Thomas Jefferson University Kimmel Cancer Center Incyte, Immunogen, Celsion, Flatiron A,C Program Committee
Schimmer Aaron Princess Margaret Cancer Centre Theravance; Takeda Pharmaceuticals; Otsuka; Novartis; Myovant; Medivir AB; Jazz Pharmaceuticals; AbbVie
G,H,S Speaker
Schmitt Clemens Charité - Universitätsmedizin Berlin No Relationships Speaker
Schwartz Lawrence Columbia University Medical Center No Relationships Speaker
Scott James AstraZeneca AstraZeneca E Speaker
Scroggins Mary In My Sister’s Care and Pinkie Hugs, LLC No Relationships Program Committee
Sequist Lecia Massachusetts General Hospital Novartis; LOXO; Janssen; Genentech; Boehringer Ingelheim; Blueprint Medicines; AstraZeneca
C,G,H Speaker
Shahrokh Esfahani Mohammad Stanford University No Relationships Speaker
Shalek Alex MIT Honeycomb Biotechnologies, Merck, Cellarity, Repertoire, Orche, Dalia
C,A,S Speaker
Sharma Padmanee UT MD Anderson Cancer Center Oncolytics, Jounce, BioAtla, Forty-Seven, Polaris, Marker, Codiak, ImaginAB, Hummingbird, Dragonfly, Lytix, Lava Therapeutics, and Achelois; Jounce; Constellation, Oncolytics, Apricity Health, Hummingbird, Dragonfly, Lytix, Lava Therapeutics, Achelois,
C,S,O Speaker
Last Name First Name Company Relationships Type Role
25
DISCLOSURE OF FINANCIAL RELATIONSHIPS
Sharp Phillip Koch Institute for Integrative Cancer Research at MIT Vir Biotechnology; Syros Pharmaceuticals; Skyhawk Therapeutics; Dewpoint Therapeutics; Alnylam Pharmaceuticals
A,C,S Speaker
Sharpless Norman National Cancer Institute No Relationships Speaker
Shen Hui Van Andel Research Institute AnchorDx S Program Committee, Speaker
Sherman Mara Oregon Health & Science University No Relationships Speaker
Shi Xingyi Boston University School of Medicine No Relationships Speaker
Shields Anthony Barbara Ann Karmanos Cancer Institute Caris Life Sciences, Inovio, ImaginAb, Xencor, Incyte, Daiichi, MSK, Plexxikon, H3 Biomedicine, Eisai, LSK BioPartners, Inc, Halozyme, Inc, Lexicon, Boehringer Ingelheim, Exelexis, Bayer, Taiho, Torque, AstraZeneca, Astellas
G Program Committee
Shokat Kevan UCSF Wellspring Biosciences/Araxes; Revolution Medicines (https://revmed.com); QuLab, Inc.; Merck, Inc.; Kura Oncology; Kumquat Biosciences; Janssen Pharmaceuticals; Genentech/Roche; Dice Molecules; Denali Therapeutics; Erasca; Venthera; Mitokin
A,C,S Speaker
Shyr Yu Vanderbilt-Ingram Cancer Center Roche, Janssen, Pfizer, Aduro Biotech, Novartis C Program Committee
Singh Anand National Cancer Institute, NIH No Relationships Speaker
Singh Bhuminder Vanderbilt University Medical Center No Relationships Speaker
Singh Harpreet U.S. Food and Drug Administration No Relationships Speaker
Smith Catherine UCSF Revolution Medicines; Fuji Film; Daiichi Sanyko; Astellas Pharma; Amgen; AbbVie
A,G,H Speaker
Smith Victoria Amphivena Therapeutics Inc Amphivena Therapeutics Inc E Speaker
Socinski Mark Florida Hospital Cancer Institute Genentech, Lilly, Spectrum, Novartis, AZ, BMS, Guardant, Celgene
A,G,H,SB Program Committee
Solanki Hitendra H. Lee Moffitt Cancer Center No Relationships Speaker
Song Minkyo National Cancer Institute No Relationships Speaker
Soria Jean-Charles MedImmune AZ, Gritstone E,S Program Committee
Last Name First Name Company Relationships Type Role
26
DISCLOSURE OF FINANCIAL RELATIONSHIPS
Sosa Maria Icahn School of Medicine at Mount Sinai Loxo; Exelixis; GlaxoSmithKline, Novo Nordisk, AstraZeneca, Eli Lilly
A,G,O Speaker
Speicher Michael Medical University of Graz Servier; Janssen Oncology G,H Speaker
Staudt Louis NCI-CCR No Relationships Program Committee
Steeg Patricia National Cancer Institute AstraZeneca/MedImmune G Speaker
Steele Maria Perlmutter Cancer Center at NYU Langone Health No Relationships Speaker
Steele Nina UM No Relationships Speaker
Stellas Dimitris National Cancer Institute at Frederick No Relationships Speaker
Stevens Rick Argonne National Laboratory No Relationships Speaker
Stewart Sheila Washington University Aclaris G Program Committee, Speaker
Stiff Andrew Ohio State University College of Medicine No Relationships Speaker
Stover Elizabeth Dana-Farber Cancer Institute No Relationships Speaker
Stroh Christopher Translational Innovation Platform, Oncology, Merck KGaA
Translational Innovation Platform, Oncology, Merck KGaA
E Speaker
Stromnes Ingunn University of Minnesota Luminary Therapeutics A Speaker
Stupp Roger Northwestern University Novartis, Bayer Pharma, Northwest Bio, ZaiLab C,SB,O Program Committee
Subklewe Marion The Gene Center Munich No Relationships Speaker
Sun Fangxian Sanofi US Sanofi US E Speaker
Sun Weijing University of Kansas Medical Center Merck, Agios, Taho A,C,G,SB Program Committee, Speaker
Sutcliffe Julie University of California, Davis (UC Davis) Luminance BioSciences, Inc; Cellsight Technologies, Inc.
A,C,G,S Speaker
Swanton Charles The Francis Crick Institute and UCL Cancer Institute Pfizer, Novartis, GlaxoSmithKline, MSD, BMS, Celgene, AstraZeneca, Illumina, Sarah Canon Research Institute, Genentech, Roche-Ventana, GRAIL, Medicxi. Advisor for Dynamo Therapeutics, BI, Apogen Biotechnologies, Epic Bioscience, GRAIL, Achilles Therapeutics
A,C,G, H,S
Program Committee
Swartz Melody University of Chicago No Relationships Speaker
Last Name First Name Company Relationships Type Role
27
DISCLOSURE OF FINANCIAL RELATIONSHIPS
Sweet-Cordero Alejandro UCSF No Relationships Program Committee
Szalai Bence Semmelweis University No Relationships Speaker
Takahashi Hideyuki Gunma University No Relationships Speaker
Tao Ting Dana-Farber Cancer Institute No Relationships Speaker
Taube Janis Johns Hopkins University School of Medicine Merck & Co; Compugen; Bristol-Myers Squibb; AstraZeneca; Akoya Biosciences
A,C,G,O Speaker
Taunton Jack UCSF Principia; Pfizer; Kezar Life Sciences; Global Blood Therapeutics; Genentech; Cedilla Therapeutics
C,G,H,S Speaker
Teng Michele QIMR Berghofer Medical Research Institute BMS, MSD, Arcus, Novartis, Roche, BI, Tizona C,SB Speaker
Terry Mary Beth Columbia University School of Public Health No Relationships Program Committee
Theodorescu Dan Cedars-Sinai Medical Center Urogen Pharma, Machavert Pharamaceuticals, Merck Sharp & Dohme Corp, Aurora Oncology, Lahjavida, Synlogic
C,S Program Committee
Theoret Marc U.S. Food and Drug Administration No Relationships Speaker
Thiery Jean-Paul Institute Gustave Roussy Biosyngen PTE LTD Singapre; Biocheetah PTE LTD Singapore; Aimaginostics PTE LTD Singapore
A,C Speaker
Timpson Paul Garvan Institute of Medical Research INxmed; Amplia C Speaker
Ting Angela The Cleveland Clinic No Relationships Speaker
Tomasetti Cristian Johns Hopkins University School of Medicine Thrive O Speaker
Trent Jeffrey TGen (The Translational Genomics Research Institute) No Relationships Speaker
Tripathi Brajendra National Cancer Institute No Relationships Speaker
Tschurtschenthaler Markus Technical University of Munich No Relationships Speaker
Tseng Yuen-Yi Broad Institute of MIT and Harvard No Relationships Speaker
Tucker-Kellogg Lisa Duke-NUS Medical School No Relationships Speaker
Turcotte Amelie Université Laval No Relationships Speaker
Tyner Jeffrey OHSU Knight Cancer Institute Syros; Seattle Genetics; Petra; Janssen; Incyte; Gilead; Genentech; Constellation Pharmaceuticals; AstraZeneca; Aptose Biosciences
G Speaker
Last Name First Name Company Relationships Type Role
28
DISCLOSURE OF FINANCIAL RELATIONSHIPS
Ulrich Cornelia Huntsman Cancer Institute No Relationships Program Committee
Umar Asad NCI-DCP No Relationships Speaker
Ushijima Toshikazu National Cancer Center Research Institute No Relationships Speaker
Valeri Nicola Royal Marsden Hospital Institute of Cancer Res. Pfizer; Merck Serono; Eli Lilly; Bayer SB Speaker
Valk Peter Erasmus Medical Center No Relationships Speaker
van Riet Job Erasmus MC No Relationships Speaker
Van Tine Brian Washington University Lilly, Epizyme, CytRx, Janssen, Caris, Pfizer, Merck, Immune Design, Daiichi Sankyo, Adaptimmune, Plexxicon, Tracon, Bayer
A,C,G,SB Program Committee
Van Valen David California Institute of Technology No Relationships Speaker
Varner Judith UCSD Moores Cancer Center VLP Therapeutics; Second Genome; MiNA Therapeutics; Gossamer; Argent Therapeutics; AlphaBeta Therapeutics
A,C,G, S,O
Speaker
Vasan Neil Memorial Sloan Kettering Cancer Center Volastra Therapeutics; Petra Pharma; Novartis A,C,H Speaker
Vasbinder Melissa Ribon Theraspeutics Inc Ribon Therapeutics E,S Program Committee
Vickovic Sanja Broad Institute of MIT and Harvard No Relationships Speaker
Vilar-Sanchez Eduardo UT MD Anderson Cancer Center TFS KOL; Janssen Research and Development A,C,H Speaker
Viswanadhapalli Suryavathi UT Health San Antonio No Relationships Speaker
Wages Nolan University of Virginia No Relationships Speaker
Walsh Bill Healthy Building Network No Relationships Speaker
Wan Liling University of Pennsylvania No Relationships Speaker
Wang C.K. COTA Healthcare No Relationships Speaker
Wang Jean Princess Margaret Cancer Centre Trillium Therapeutics Inc. (TTI) O Speaker
Wang Ting Washington University School of Medicine No Relationships Speaker
Wang Xiaojing Genentech, Inc. Genentech, EQRx E Speaker
Ward Mary National Cancer Institute No Relationships Speaker
Ward Richard AstraZeneca AstraZeneca Pharmaceuticals E Speaker
Last Name First Name Company Relationships Type Role
29
DISCLOSURE OF FINANCIAL RELATIONSHIPS
Wargo Jennifer UT MD Anderson Cancer Center Roche/Genentech, Novartis, AstraZeneca, GSK, BMS, Merck, Microbiome DX, Biothera Pharmaceuticals, Imedex, Dava Oncology, Omniprex, Illumina, Gilead, MedImmune, Patent Application, PeerView, Physician Education Resource, Exelixis
A,C,E,G, SB,O
Program Committee, Speaker
Watowich Stephanie UT MD Anderson Cancer Center Ridgeline Therapeutics E,O Program Committee, Speaker
Watson Philip Memorial Sloan Kettering Cancer Center No Relationships Speaker
Weeraratna Ashani The Sidney Kimmel Cancer Center at Johns Hopkins School of Medicine
Phoremost Technologies A Speaker
Wei Jia The Comprehensive Cancer Center of Drum-Tower Hospital, Medical School of Nanjing University & Clinical Cancer Institute of Nanjing University
No Relationships Speaker
Wei Jun National Cancer Inst. No Relationships Speaker
Weichselbaum Ralph University of Chicago Cancer Research Center NKMax America Inc; Nano proteagen; Merck Serono, S.A.; Magi Therapeutics; ImmunoVir LLC; Genus; Coordination Pharmaceuticals Inc; Boost Therapeutics Inc.; Astrazeneca; Aettis Inc.
C,S,O Speaker
Weiner David The Wistar Institute Sanofi; Inovio; Geneos; GeneOne; BBI; AstraZeneca
A,C,G,S Speaker
Wenzel Alexander UC San Diego No Relationships Speaker
Westcott Peter MIT Koch Institute for Integrated Cancer Res. No Relationships Speaker
Wherry Edward University of Pennsylvania Merck; Roche; Pieris; Elstar; Surface Oncology; Eli Lilly; Celgene; MedImmune; Bristol-Myers Squibb; Arsenal Biosciences; Arcus; DynaVax, KyMab
C,G,H, S,O
Speaker
Whitley Owen University of Toronto No Relationships Speaker
Winn Robert Virginia Commonwealth University, Massey Cancer Center
No Relationships Speaker
Last Name First Name Company Relationships Type Role
30
DISCLOSURE OF FINANCIAL RELATIONSHIPS
Wistuba Ignacio UT MD Anderson Cancer Center Genentech/Roche, Astra Zeneca/Medimmune, MSD, Pfizer, Bristol-Myers Squibb, Bayer, HTG Molecular, Asuragen, Merck, GlaxoSmithKline, Guardant Health, Oncoplex, HTG Molecular, DepArray, Merck, Adaptive, Adaptimmune, EMD Serono, Takeda, Amgen, Karus, Johnson & Johnson, Bayer, Iovance, 4D, Novartis, Akoya
A,G,SB Program Committee
Wolchok Jedd Memorial Sloan Kettering Cancer Center Adaptive Biotech; Advaxis; Amgen; Apricity; Array BioPharma; Ascentage Pharma; Bayer; Beigene; Bristol Myers Squibb; Chugai; Elucida; Eli Lilly; F Star; Genentech; Imvaq; Kyowa Hakko Kirin; Merck; Neon Therapuetics; Northern Biologics; Ono; Polaris Pharma; Polynoma; Psioxus; Recepta; Takara Bio; Trieza; Sellas Life Sciences; Serametrix; Surface Oncology; Syndax,; Syntalogic; MedImmune; Potenza; Tizona; Linnaeus
C,G,S Speaker
Wong Jason National Cancer Institute No Relationships Speaker
Wood Laura Johns Hopkins University School of Medicine No Relationships Speaker
Wozniak Agnieszka KU Leuven No Relationships Speaker
Wu Guojun Barbara Ann Karmanos Cancer Institute No Relationships Speaker
Wu Ronald University of Toronto No Relationships Speaker
Yala Adam Massachusetts Institute of Technology No Relationships Speaker
Yamauchi Takayoshi Roswell Park Comprehensive Cancer Center No Relationships Speaker
Yang Jing University of California, San Diego No Relationships Program Committee, Speaker
Yap Timothy UT MD Anderson Cancer Center AZ, Bayer, Pfizer, Tesaro, Jounce, Eli Lilly, Seattle Genetics, Kyowa, Constellation, Aduro, Almac, AstraZeneca, Atrin, Bayer, Bristol-Myers Squibb, Calithera, Clovis, Cybrexa, EMD Serono, Ignyta, Jansen, Merck, Pfizer, Roche, Vertex Pharmaceuticals
SB,C,G Speaker
Ye Jiangbin Stanford University School of Medicine No Relationships Speaker
Yip Stephen University of British Columbia Bayer, Pfizer, Roche A,H Program Committee
Last Name First Name Company Relationships Type Role
31
DISCLOSURE OF FINANCIAL RELATIONSHIPS
Yoon Hyung-Suk Vanderbilt University Medical Center No Relationships Speaker
Yu David Emory University School of Medicine No Relationships Speaker
Yu Jennifer The Cleveland Clinic No Relationships Program Committee, Speaker
Yu Xin Rutgers Cancer Institute of New Jersey No Relationships Speaker
Yuan Guo-Cheng Harvard T.H. Chan School of Public Health No Relationships Speaker
Yuan Jian-Min University of Pittsburgh No Relationships Speaker
Yue Feng Northwestern University No Relationships Speaker
Zacharakis Nikolaos NIH-NCI (National Cancer Institute) No Relationships Speaker
Zhang Bing Baylor College of Medicine TNIK Therapeutics; Bristol-Myers Squibb C,G Speaker
Zhang Xuehong Harvard Medical School No Relationships Speaker
Zhang Yin Brigham and Women’s Hospital and Harvard Medical School
No Relationships Speaker
Zhou Ting Yale School of Medicine No Relationships Speaker
Zitvogel Laurence Institute Gustave Roussy Transgene; Lytix Biopharma; Kaleido; Innvovate Pharma; GSK; everImmune; EpiVax
A,G,H,S Speaker
Zou Weiping University of Michigan Oncopia; Hengenix Biotech; Hengenix; CStone A Speaker
Zuo Qianying University of Illinois at Urbana-Champaign No Relationships Speaker